NPI: 1356366314 · WEST COLUMBIA, SC 29169 · General Acute Care Hospital · NPI assigned 07/12/2006
Authorized official SARVIS, MELINDA controls 20+ related entities in our dataset. Read more
| Authorized Official | SARVIS, MELINDA (EXECUTIVE VICE PRESIDENT) |
| NPI Enumeration Date | 07/12/2006 |
Other providers sharing the same authorized official: SARVIS, MELINDA
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 291,039 | $5.93M |
| 2019 | 316,711 | $6.45M |
| 2020 | 328,050 | $6.29M |
| 2021 | 28,161 | $598K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 36415 | Collection of venous blood by venipuncture | 37,133 | 25,201 | $2.72M |
| J7030 | Infusion, normal saline solution , 1000 cc | 11,815 | 9,084 | $2.33M |
| 80053 | Comprehensive metabolic panel | 39,987 | 33,757 | $1.61M |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 20,394 | 18,697 | $871K |
| J7050 | Infusion, normal saline solution, 250 cc | 8,912 | 4,444 | $845K |
| 86900 | 6,298 | 5,651 | $737K | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 4,154 | 3,532 | $634K |
| 80048 | Basic metabolic panel (calcium, ionized) | 19,014 | 14,109 | $477K |
| A9577 | Injection, gadobenate dimeglumine (multihance), per ml | 552 | 470 | $442K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 13,362 | 12,638 | $415K |
| 81001 | 27,676 | 23,976 | $361K | |
| 84439 | 10,392 | 9,854 | $299K | |
| 99284 | Emergency department visit for the evaluation and management, high severity | 22,047 | 19,232 | $269K |
| 87480 | 3,139 | 3,008 | $242K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 18,194 | 16,469 | $225K |
| 86703 | 7,087 | 6,734 | $225K | |
| 86695 | 1,178 | 1,132 | $218K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 7,392 | 6,218 | $215K |
| 82565 | 1,073 | 995 | $196K | |
| 87081 | 11,995 | 11,709 | $189K | |
| 87077 | 7,732 | 7,025 | $185K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1,639 | 1,560 | $154K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 2,806 | 2,526 | $151K |
| 71250 | 854 | 788 | $150K | |
| 93971 | 993 | 920 | $141K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 4,857 | 4,655 | $140K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 484 | 453 | $133K |
| 83021 | 1,080 | 1,009 | $126K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 4,212 | 3,305 | $124K |
| 71046 | Radiologic examination, chest; 2 views | 5,491 | 5,057 | $122K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 2,439 | 2,256 | $121K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 3,640 | 3,305 | $114K |
| 70450 | Computed tomography, head or brain; without contrast material | 6,157 | 5,541 | $112K |
| 82962 | 5,160 | 2,934 | $103K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 10,232 | 5,274 | $102K |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 15,341 | 12,743 | $99K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 3,693 | 1,179 | $97K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 575 | 520 | $95K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 6,916 | 6,592 | $90K |
| 84702 | 6,268 | 4,852 | $90K | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 1,514 | 1,316 | $89K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 4,597 | 4,167 | $86K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 924 | 848 | $83K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 2,460 | 2,361 | $82K |
| 71045 | Radiologic examination, chest; single view | 11,271 | 9,576 | $71K |
| 80061 | Lipid panel | 8,737 | 8,383 | $70K |
| 72141 | 180 | 167 | $69K | |
| 82950 | 3,599 | 3,541 | $69K | |
| 87210 | 1,518 | 1,411 | $65K | |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | 216 | 205 | $65K |
| 77336 | 533 | 223 | $62K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 1,636 | 1,320 | $57K |
| 87070 | 1,890 | 1,717 | $57K | |
| 73030 | 1,070 | 966 | $56K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 45,488 | 36,287 | $55K |
| U0001 | Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel | 677 | 636 | $54K |
| 84443 | Thyroid stimulating hormone (TSH) | 17,800 | 16,726 | $53K |
| 82607 | 2,166 | 2,032 | $49K | |
| 77062 | 258 | 245 | $49K | |
| 73610 | 801 | 726 | $48K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | 1,589 | 1,467 | $48K |
| 77300 | 61 | 52 | $46K | |
| 93970 | 384 | 355 | $45K | |
| 77066 | Tomosynthesis, mammo | 819 | 790 | $45K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 449 | 393 | $43K |
| 85027 | 17,683 | 14,277 | $42K | |
| 73630 | 1,030 | 871 | $42K | |
| 72100 | 1,435 | 1,341 | $42K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 13,586 | 11,532 | $41K |
| 76642 | 1,144 | 973 | $41K | |
| 86038 | 1,441 | 1,382 | $41K | |
| 72040 | 653 | 612 | $41K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | 398 | 390 | $38K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 19,053 | 15,772 | $37K |
| 73564 | 1,204 | 1,022 | $35K | |
| G0378 | Hospital observation service, per hour | 18,275 | 5,109 | $34K |
| 73130 | 743 | 633 | $33K | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | 81 | 76 | $33K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 481 | 457 | $32K |
| 80076 | 2,366 | 2,174 | $31K | |
| 81025 | 11,904 | 10,759 | $31K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 2,374 | 2,228 | $30K |
| 83036 | Hemoglobin; glycosylated (A1C) | 4,212 | 3,982 | $30K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 1,130 | 1,054 | $29K |
| 81511 | 339 | 322 | $28K | |
| 73110 | 413 | 386 | $28K | |
| Q0163 | Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen | 1,103 | 824 | $26K |
| 76830 | Ultrasound, transvaginal | 740 | 702 | $23K |
| 72125 | Computed tomography, cervical spine; without contrast material | 1,387 | 1,281 | $22K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 995 | 965 | $21K |
| 82728 | 2,124 | 1,921 | $21K | |
| J1650 | Injection, enoxaparin sodium, 10 mg | 2,329 | 436 | $21K |
| 70486 | 422 | 400 | $21K | |
| 84112 | 248 | 237 | $21K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 8,998 | 6,298 | $20K |
| 74018 | 820 | 752 | $18K | |
| 78306 | 37 | 25 | $17K | |
| 86140 | 3,430 | 3,003 | $17K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 4,959 | 3,513 | $17K |
| C1729 | Catheter, drainage | 124 | 68 | $17K |
| J1815 | Injection, insulin, per 5 units | 1,949 | 777 | $16K |
| 73502 | 755 | 685 | $16K | |
| 83735 | 6,415 | 5,051 | $16K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 932 | 847 | $15K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 7,161 | 2,856 | $15K |
| 85610 | 12,580 | 10,502 | $15K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 9,360 | 5,331 | $15K |
| 88142 | 1,262 | 1,176 | $15K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 199 | 186 | $14K |
| 83001 | 481 | 457 | $14K | |
| 86225 | 875 | 852 | $14K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 14,531 | 10,922 | $14K |
| 86850 | 5,307 | 4,835 | $14K | |
| 83690 | 11,218 | 9,702 | $14K | |
| J7120 | Ringers lactate infusion, up to 1000 cc | 8,141 | 6,484 | $14K |
| 76536 | 190 | 179 | $13K | |
| 96361 | Intravenous infusion, hydration; each additional hour | 6,124 | 5,323 | $13K |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 17,498 | 5,555 | $12K |
| 88304 | 1,257 | 1,076 | $12K | |
| 82550 | 1,539 | 1,225 | $12K | |
| 83540 | 2,453 | 2,265 | $11K | |
| 84550 | 1,144 | 1,034 | $11K | |
| 10060 | 46 | 43 | $10K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1,364 | 1,291 | $10K |
| 76770 | 272 | 247 | $9K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 289 | 271 | $9K |
| 87045 | 177 | 170 | $9K | |
| 84146 | 387 | 373 | $9K | |
| 87507 | 42 | 39 | $9K | |
| 82731 | 102 | 99 | $9K | |
| 82570 | 1,907 | 1,748 | $9K | |
| 96376 | 7,399 | 3,257 | $8K | |
| 97161 | 1,433 | 1,079 | $8K | |
| 86704 | 2,116 | 2,034 | $8K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 1,329 | 879 | $8K |
| 85378 | 3,364 | 3,092 | $8K | |
| 96375 | Therapeutic injection; each additional sequential IV push | 11,391 | 8,505 | $8K |
| J2704 | Injection, propofol, 10 mg | 5,825 | 4,814 | $7K |
| 76801 | 1,927 | 1,672 | $7K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 439 | 395 | $7K |
| J2550 | Injection, promethazine hcl, up to 50 mg | 3,179 | 2,534 | $7K |
| 73080 | 103 | 98 | $7K | |
| 77412 | 165 | 12 | $7K | |
| 82043 | 912 | 890 | $7K | |
| 83880 | 4,835 | 4,104 | $7K | |
| 77065 | Tomosynthesis, mammo | 280 | 260 | $6K |
| C1769 | Guide wire | 1,425 | 990 | $6K |
| 77334 | 17 | 14 | $6K | |
| 84484 | 10,064 | 7,938 | $6K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 9,573 | 7,122 | $6K |
| 86706 | 2,315 | 2,210 | $6K | |
| 70491 | 41 | 41 | $6K | |
| 73560 | 182 | 127 | $5K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 1,141 | 298 | $5K |
| 82784 | 100 | 86 | $5K | |
| 87205 | 1,958 | 1,730 | $5K | |
| 73090 | 122 | 106 | $5K | |
| 88307 | 458 | 381 | $5K | |
| 83655 | 429 | 393 | $5K | |
| 84155 | 333 | 310 | $4K | |
| 86235 | 1,094 | 772 | $4K | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 5,096 | 4,383 | $4K |
| 82746 | 775 | 726 | $4K | |
| 93226 | 13 | 12 | $4K | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 156 | 129 | $4K |
| J1170 | Injection, hydromorphone, up to 4 mg | 4,595 | 3,137 | $4K |
| 87040 | 2,649 | 1,881 | $4K | |
| 70496 | 13 | 12 | $4K | |
| 93225 | 101 | 89 | $4K | |
| 74022 | 468 | 431 | $4K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 68 | 66 | $4K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 3,732 | 2,804 | $4K |
| 82951 | 671 | 637 | $3K | |
| 87340 | 6,853 | 6,453 | $3K | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 1,721 | 1,286 | $3K |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 913 | 735 | $3K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 3,802 | 2,631 | $3K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 155 | 64 | $3K |
| 76819 | Fetal biophysical profile; without non-stress testing | 50 | 41 | $3K |
| 86160 | 622 | 501 | $3K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 1,827 | 1,692 | $3K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 324 | 287 | $3K |
| J3480 | Injection, potassium chloride, per 2 meq | 21 | 12 | $3K |
| 84403 | 377 | 353 | $3K | |
| 88342 | 859 | 729 | $3K | |
| 82805 | 793 | 646 | $3K | |
| 85730 | 10,329 | 8,828 | $3K | |
| 84145 | 785 | 571 | $3K | |
| J2060 | Injection, lorazepam, 2 mg | 2,056 | 1,512 | $3K |
| 87486 | 165 | 134 | $2K | |
| 82785 | 71 | 65 | $2K | |
| 82670 | 37 | 36 | $2K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 7,997 | 6,041 | $2K |
| 86769 | 34 | 32 | $2K | |
| J1644 | Injection, heparin sodium, per 1000 units | 5,581 | 1,861 | $2K |
| 12001 | 27 | 26 | $2K | |
| 97165 | 620 | 419 | $2K | |
| 85652 | 3,123 | 2,744 | $2K | |
| 85049 | 13 | 12 | $2K | |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | 2,714 | 876 | $2K |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 1,040 | 887 | $2K |
| J0690 | Injection, cefazolin sodium, 500 mg | 3,150 | 2,388 | $2K |
| 86780 | 6,701 | 6,361 | $2K | |
| 83516 | 61 | 55 | $2K | |
| 85613 | 42 | 40 | $2K | |
| 87186 | 5,770 | 5,203 | $2K | |
| J3475 | Injection, magnesium sulfate, per 500 mg | 714 | 527 | $2K |
| P9016 | Red blood cells, leukocytes reduced, each unit | 336 | 261 | $2K |
| 86803 | 7,185 | 6,818 | $2K | |
| 73590 | 123 | 93 | $2K | |
| 84153 | 187 | 176 | $2K | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 1,990 | 1,603 | $2K |
| 84156 | 1,576 | 1,293 | $2K | |
| 87632 | 87 | 76 | $2K | |
| 72070 | 67 | 58 | $2K | |
| 80164 | 325 | 277 | $2K | |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 1,486 | 1,293 | $2K |
| J1940 | Injection, furosemide, up to 20 mg | 1,356 | 670 | $2K |
| 93017 | 108 | 106 | $2K | |
| Q9954 | Oral magnetic resonance contrast agent, per 100 ml | 1,247 | 1,121 | $1K |
| J8540 | Dexamethasone, oral, 0.25 mg | 38 | 27 | $1K |
| 77061 | 14 | 14 | $1K | |
| 83605 | 2,199 | 1,620 | $1K | |
| 82947 | 105 | 94 | $1K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 831 | 792 | $1K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 521 | 460 | $1K |
| J7510 | Prednisolone oral, per 5 mg | 57 | 56 | $1K |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 1,487 | 747 | $1K |
| 83550 | 1,664 | 1,492 | $1K | |
| 82525 | 215 | 209 | $1K | |
| 87631 | 116 | 94 | $1K | |
| 73140 | 26 | 26 | $1K | |
| 83520 | 40 | 40 | $1K | |
| 86431 | 998 | 968 | $1K | |
| 36430 | 382 | 291 | $1K | |
| 97116 | 730 | 237 | $1K | |
| 86200 | 515 | 499 | $952.88 | |
| 82533 | 60 | 52 | $918.14 | |
| J3370 | Injection, vancomycin hcl, 500 mg | 1,158 | 514 | $845.46 |
| 87807 | 89 | 81 | $822.47 | |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | 1,042 | 858 | $821.75 |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | 766 | 633 | $789.42 |
| Q9961 | High osmolar contrast material, 250-299 mg/ml iodine concentration, per ml | 159 | 67 | $779.86 |
| 97162 | 28 | 25 | $678.07 | |
| 84270 | 91 | 86 | $653.14 | |
| 86762 | 3,863 | 3,615 | $645.44 | |
| 86901 | 6,299 | 5,651 | $629.39 | |
| 82150 | 191 | 181 | $594.97 | |
| 82553 | 23 | 12 | $559.47 | |
| 84481 | 707 | 685 | $549.10 | |
| 73552 | 18 | 15 | $520.66 | |
| 83970 | 149 | 126 | $478.58 | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 2,074 | 1,824 | $466.24 |
| J0360 | Injection, hydralazine hcl, up to 20 mg | 937 | 653 | $429.35 |
| 85660 | 1,002 | 934 | $415.60 | |
| 83615 | 377 | 283 | $415.54 | |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | 296 | 125 | $410.52 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 13,354 | 12,630 | $393.25 |
| 83013 | 13 | 13 | $365.45 | |
| A9270 | Non-covered item or service | 95 | 70 | $364.77 |
| 83525 | 164 | 157 | $351.88 | |
| 84144 | 12 | 12 | $351.45 | |
| 82103 | 12 | 12 | $339.91 | |
| 87493 | 25 | 24 | $327.52 | |
| 87641 | 27 | 27 | $223.68 | |
| 86787 | 1,845 | 1,726 | $222.02 | |
| 82747 | 716 | 676 | $183.80 | |
| 84132 | 187 | 143 | $172.07 | |
| J3486 | Injection, ziprasidone mesylate, 10 mg | 1,195 | 695 | $162.82 |
| 82140 | 113 | 85 | $155.16 | |
| 85045 | 1,108 | 833 | $133.71 | |
| 87075 | 706 | 608 | $129.76 | |
| 86141 | 69 | 65 | $127.47 | |
| 86709 | 2,056 | 1,971 | $121.91 | |
| 85014 | 256 | 99 | $119.22 | |
| 86039 | 1,226 | 1,174 | $104.04 | |
| 86376 | 70 | 69 | $77.39 | |
| 86480 | 49 | 46 | $76.49 | |
| 90715 | 700 | 658 | $62.02 | |
| 87522 | Neg quan hep c or qual rna | 12 | 12 | $57.97 |
| 83883 | 14 | 12 | $54.50 | |
| 81015 | 49 | 47 | $51.73 | |
| 88173 | 113 | 106 | $42.01 | |
| 82105 | 12 | 12 | $40.77 | |
| 83090 | 26 | 25 | $38.60 | |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | 118 | 87 | $38.08 |
| 86777 | 113 | 107 | $37.13 | |
| 84100 | 1,070 | 896 | $33.23 | |
| 86256 | 80 | 78 | $32.54 | |
| 84425 | 351 | 345 | $28.74 | |
| 82247 | 20 | 13 | $23.98 | |
| 87899 | 58 | 54 | $18.62 | |
| 86923 | 417 | 291 | $7.85 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 319 | 295 | $7.00 |
| J0744 | Injection, ciprofloxacin for intravenous infusion, 200 mg | 449 | 301 | $0.00 |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | 762 | 518 | $0.00 |
| J0780 | Injection, prochlorperazine, up to 10 mg | 249 | 222 | $0.00 |
| 84630 | 165 | 160 | $0.00 | |
| 86696 | 1,171 | 1,125 | $0.00 | |
| 84165 | 468 | 435 | $0.00 | |
| 87660 | 3,146 | 3,015 | $0.00 | |
| 77012 | 16 | 15 | $0.00 | |
| 84597 | 130 | 126 | $0.00 | |
| C1887 | Catheter, guiding (may include infusion/perfusion capability) | 113 | 91 | $0.00 |
| J3105 | Injection, terbutaline sulfate, up to 1 mg | 116 | 92 | $0.00 |
| 86147 | 14 | 14 | $0.00 | |
| C1751 | Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) | 32 | 24 | $0.00 |
| 86334 | 40 | 39 | $0.00 | |
| 84460 | 27 | 26 | $0.00 | |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 18 | 14 | $0.00 |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 135 | 90 | $0.00 |
| J1953 | Injection, levetiracetam, 10 mg | 117 | 71 | $0.00 |
| 96367 | 71 | 53 | $0.00 | |
| J2300 | Injection, nalbuphine hydrochloride, per 10 mg | 127 | 65 | $0.00 |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 28 | 27 | $0.00 |
| 10005 | 16 | 15 | $0.00 | |
| J1245 | Injection, dipyridamole, per 10 mg | 21 | 13 | $0.00 |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 94 | 79 | $0.00 |
| 93458 | 97 | 90 | $0.00 | |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 292 | 238 | $0.00 |
| 97535 | Self-care/home management training, each 15 minutes | 252 | 128 | $0.00 |
| 87510 | 3,139 | 3,008 | $0.00 | |
| J3411 | Injection, thiamine hcl, 100 mg | 17 | 12 | $0.00 |
| 88341 | 79 | 68 | $0.00 | |
| 82952 | 665 | 630 | $0.00 | |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 92 | 89 | $0.00 |
| J7042 | 5% dextrose/normal saline (500 ml = 1 unit) | 171 | 97 | $0.00 |
| 86778 | 113 | 107 | $0.00 | |
| 87046 | 165 | 158 | $0.00 | |
| G8980 | Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting | 14 | 13 | $0.00 |
| 20610 | 26 | 24 | $0.00 | |
| 90686 | 53 | 38 | $0.00 | |
| J1630 | Injection, haloperidol, up to 5 mg | 42 | 37 | $0.00 |
| 88311 | 26 | 25 | $0.00 | |
| 83921 | 73 | 72 | $0.00 | |
| 86800 | 66 | 64 | $0.00 | |
| 83002 | 66 | 64 | $0.00 | |
| 85018 | 187 | 81 | $0.00 | |
| 74021 | 36 | 36 | $0.00 | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 67 | 34 | $0.00 |
| 84480 | 14 | 14 | $0.00 | |
| 70498 | 14 | 13 | $0.00 | |
| 87581 | 165 | 134 | $0.00 | |
| G0379 | Direct admission of patient for hospital observation care | 16 | 15 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 22 | 12 | $0.00 |
| J1335 | Injection, ertapenem sodium, 500 mg | 46 | 24 | $0.00 |
| C2617 | Stent, non-coronary, temporary, without delivery system | 46 | 26 | $0.00 |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | 14 | 14 | $0.00 |